Power, CA
David Power, Trabuco Canyon, CA US
Patent application number | Description | Published |
---|---|---|
20090298753 | METHODS FOR THE THERAPEUTIC USE OF CYCLOSPORINE COMPONENTS - Methods of treating humans or animals having various conditions are disclosed which include administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the condition. Among the conditions treated are systemic lupus eryhematosis, multiple sclerosis, maloplabia of the skin, oral frictional hyperkeratosis, oral manifestations of autoimmune blistering disease, oral lichen planus, aphthous ulcers, nasal polyps, rhinosporiodosis, sinusitis, iritis, carcinoid lung, laryngitis and atrophic gastritis. | 12-03-2009 |
David F. Power, Trabuco Canyon, CA US
Patent application number | Description | Published |
---|---|---|
20090136514 | Tetracyclines for Treating Ocular Diseases and Disorders - Methods and compositions are disclosed for treating a patient suffering from a condition associated with a retinal and/or choroidal disease or disorder of the eye involving endothelial cell dysfunction, especially vascular endothelial cells of the eye, and especially before or in the absence of neovascularization. The therapeutic method involves administering a tetracycline, an analog of tetracycline, or a chemically modified tetracycline (CMT) to a patient suffering from such conditions. Also provided are compositions and methods for reducing breakdown of tight junctions in vascular endothelial cells; reducing IL-1 α concentrations; and inhibiting IL-1 α-mediated matrix metalloproteinase activity in endothelial cells of the eye and surrounding tissues. | 05-28-2009 |
20120028929 | TETRACYCLINE STABILIZING FORMULATIONS - An aqueous solution comprising a chelating agent at a concentration of about 0.1-0.5%, and an antioxidant agent at a concentration of about 0.1-0.5%, wherein the pH of the solution is between about 4.5 and about 7.5 is disclosed. The aqueous solution may comprise a tetracycline composition wherein the tetracycline is formulated in the aqueous solution. A method for reducing the rate and/or overall extent of degradation of a tetracycline in aqueous solution, comprising admixing in a tetracycline containing solution a chelating agent at a concentration of about 0.1-0.5% and an antioxidant at a concentration of about 0.1-0.5% and, as necessary, adjusting the pH of the solution so that it is between about 4.5 and about 7.5 is also disclosed. Tetracycline compositions of the invention may be used to treat inflammatory and/or tissue degeneration conditions. | 02-02-2012 |
20130137742 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN - Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein. | 05-30-2013 |
20130197051 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN - Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein. | 08-01-2013 |
20130203833 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN - Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein. | 08-08-2013 |
20130203834 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN - Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein. | 08-08-2013 |
20150057327 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN - Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein. | 02-26-2015 |
David F. Power, San Clemente, CA US
Patent application number | Description | Published |
---|---|---|
20140206626 | METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS - Methods of treating an eye of a human or animal include administering to an eye of a human or animal a composition in the form of an emulsion including water, a hydrophobic component and a cyclosporin component in a therapeutically effective amount of less than 0.1% by weight of the composition. The weight ratio of the cyclosporin exponent to the hydrophobic component is less than 0.8. | 07-24-2014 |
Donald W. Power, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090119718 | MENUING SYSTEM FOR CONTROLLING CONTENT DELIVERY WITHIN A VIDEO DISTRIBUTION SYSTEM - A menuing system for a video distribution system provides an interactive display to allow a user to select and control the delivery of program material. A central host computer processes initial request for service from users and maintains a database of currently available program materials and other system resources. In response to a user's request for service, the central host computer assigns one of a plurality of assignable computing devices (ACDs) to communicate with the user. The ACD reads the database and presents an interactive menu to the user on the user's audiovisual display monitor. Using a graphical user interface (GUI) the user may then respond to the menu by selecting an item for viewing. The menuing system may have a number of levels that the user may parse through to allow the user to select desired program material. Upon selection by the user, the ACD passes the request on for further programming. | 05-07-2009 |
Gordon G. Power, Redlands, CA US
Patent application number | Description | Published |
---|---|---|
20100247682 | USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS - It has been surprisingly discovered that administration of nitrite to subjects causes a reduction in blood pressure and an increase in blood flow to tissues. The effect is particularly beneficial, for example, to tissues in regions of low oxygen tension. This discovery provides useful treatments to regulate a subject's blood pressure and blood flow, for example, by the administration of nitrite salts. Provided herein are methods of administering a pharmaceutically-acceptable nitrite salt to a subject, for treating, preventing or ameliorating a condition selected from: (a) ischemia-reperfusion injury (e.g., hepatic or cardiac or brain ischemia-reperfusion injury); (b) pulmonary hypertension (e.g., neonatal pulmonary hypertension); or (c) cerebral artery vasospasm. | 09-30-2010 |
20120195983 | TREATMENT OF SPECIFIC CARDIOVASCULAR CONDITIONS WITH NITRITE - It has been surprisingly discovered that administration of nitrite to subjects causes a reduction in blood pressure and an increase in blood flow to tissues. The effect is particularly beneficial, for example, to tissues in regions of low oxygen tension. This discovery provides useful treatments to regulate a subject's blood pressure and blood flow, for example, by the administration of nitrite salts. Provided herein are methods of administering a pharmaceutically-acceptable nitrite salt to a subject, for treating, preventing or ameliorating a condition selected from: (a) ischemia-reperfusion injury (e.g., hepatic or cardiac or brain ischemia-reperfusion injury); (b) pulmonary hypertension (e.g., neonatal pulmonary hypertension); or (c) cerebral artery vasospasm. | 08-02-2012 |
20150125553 | USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS - It has been surprisingly discovered that administration of nitrite to subjects causes a reduction in blood pressure and an increase in blood flow to tissues. The effect is particularly beneficial, for example, to tissues in regions of low oxygen tension. This discovery provides useful treatments to regulate a subject's blood pressure and blood flow, for example, by the administration of nitrite salts. Provided herein are methods of administering a pharmaceutically-acceptable nitrite salt to a subject, for treating, preventing or ameliorating a condition selected from: (a) ischemia-reperfusion injury (e.g., hepatic or cardiac or brain ischemia-reperfusion injury); (b) pulmonary hypertension (e.g., neonatal pulmonary hypertension); or (c) cerebral artery vasospasm. | 05-07-2015 |
Marc Andrew Power, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090299940 | RULE-BASED SYSTEM FOR CLIENT-SIDE QUALITY-OF-SERVICE TRACKING AND REPORTING - Server-side control of client-side quality-of-service tracking is provided. When an event occurs at a client, a measurement client collects event parameters and generates aggregated measurement data in accordance with aggregation rules that are provided to the measurement client from a server-side measurement service. The measurement client periodically reports the aggregated measurement data to the measurement service for storage and analysis. | 12-03-2009 |
20140095708 | RULE-BASED SYSTEM FOR CLIENT-SIDE QUALITY-OF-SERVICE TRACKING AND REPORTING - Server-side control of client-side quality-of-service tracking is provided. When a service is being provided to a client device, a server provides aggregation rules to a client device as part of the service. The client device executes instructions in the aggregation rules to collect QoS metrics regarding the service on the client device and to manipulate the QoS metrics to generate aggregated QoS data. The client device reports the aggregated QoS data to a server for storage and analysis. | 04-03-2014 |
Matthew W. Power, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20100064590 | ZERO STEP SILL EXTRUDED FLUSH THRESHOLD DOOR SEAL SYSTEM - The present application is directed to a manual or automatic flush threshold door seal system used on folding exterior doors along with an alternate embodiment for conventional exterior entryway doors that will not impede the passage of a wheelchair. A flexible weather seal can be put in a retracted or down position within an aluminum extrusion imbedded within the threshold providing a flush access surface and may be raised up into the upright position providing an adequate weather seal. | 03-18-2010 |
Michael Power, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20090144840 | Beta-secretase enzyme compositions and methods - Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease. | 06-04-2009 |
20110281752 | BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS - Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease. | 11-17-2011 |
Michael A. Power, Tustin, CA US
Patent application number | Description | Published |
---|---|---|
20150378354 | Process Control Method With Integrated Database For Electronically Documenting The Configuration, Modification And Operation Of A Controlled Process - A process control method that automatically and comprehensively manages the creation, storage and use of electronic records during the operation of a controlled process and for governing and documenting the users that operate the computer systems that are involved in the creation, storage and use of the electronic records. The method controls a process, such as a chemical process, by receiving measurement information relating to the process, applying rules to the received measurement information to determine a desired response, and sending control information to at least one device associated with the process, so as to modify the process. The method maintains the rules, measurements and control activity in transaction logs or audit trails related thereto in a secure database. By providing convenient, centralized control of the process within a secure database, the method enhances compliance with the FDA regulations that permit electronic records to be regarded as the equivalent to paper records under 21 CFR Part 11. | 12-31-2015 |
Michael A. Power, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20110213485 | Process Control Method With Integrated Database For Electronically Documenting The Configuration, Modification And Operation Of A Controlled Process - A process control method that automatically and comprehensively manages the creation, storage and use of electronic records during the operation of a controlled process and for governing and documenting the users that operate the computer systems that are involved in the creation, storage and use of the electronic records. The method controls a process, such as a chemical process, by receiving measurement information relating to the process, applying rules to the received measurement information to determine a desired response, and sending control information to at least one device associated with the process, so as to modify the process. The method maintains the rules, measurements and control activity in transaction logs or audit trails related thereto in a secure database. By providing convenient, centralized control of the process within a secure database, the method enhances compliance with the FDA regulations that permit electronic records to be regarded as the equivalent to paper records under 21 CFR Part 11. | 09-01-2011 |
20140201206 | Global Deployment of Analytical Methods Via Networked Database to Mobile (Smart Phone) Technology - a method for global deployment of analytical methods and merging of data via mobile technology and remote mobile devices, the method comprising: developing analytical methods for quantification and identification to be stored in a relational database and distributed to remote mobile devices; developing execution methods to be stored in a relational database and distributed to remote mobile devices; employing a methodology incorporating gatekeeper applications to ensure full control and traceability in the development, deployment, and use of the analytical methods and the processing and distribution of data and analytical predictions; collecting field data from remote devices to a central relational database for a posterior analysis, model enhancement, and archiving; providing remote distributed access to all stored data including field data and processed data; providing a database methodology that provides for a highly level of security for the transmission of data and the storage of data; and providing a robust networking strategy to accommodate for potentially unreliable and unstable network connections | 07-17-2014 |
Michael J. Power, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090006263 | TECHNIQUE FOR SECURELY COMMUNICATING INFORMATION - A system that communicates information is described. During operation, this system receives an encryption key through a first wireless communication technique, wherein the first wireless communication technique includes near field communication. Then, the system communicates a document through a second wireless communication technique, where the document is associated with a financial transaction being conducted with a commercial establishment. Next, the system receives encrypted information through the second wireless communication technique, where the encrypted information is, at least in part, encrypted using the encryption key, and where the second wireless communication technique includes a technique other than near field communication. | 01-01-2009 |
20090252314 | ESTABLISHING AND RECOVERING CONTEXT RELATED TO AN ON-GOING SEQUENCE OF COMMUNICATIONS - Apparatus, methods, and computer program products are disclosed that teach methods for establishing context of a subsequent electronic real-time communication. One method detects a connection attempt that is initiated by an instigator-identifiable for a subsequent electronic real-time communication that is directed to a target-identifiable. The instigator-identifiable is associated with a first identification characteristic and the target-identifiable is associated with a second identification characteristic. This method subsequently retrieves a reminder reference that is responsive to the first identification characteristic and the second identification characteristic and presents the reminder reference to the target-identifiable. The method also establishes the subsequent electronic real-time communication between the instigator-identifiable and the target-identifiable. The disclosed technology also includes apparatus that perform the methods and program products that contain computer instructions that cause a computer to perform the methods when the computer executes the instructions. | 10-08-2009 |
Michael James Power, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150199667 | CLOUD-BASED POINT-OF-SALE PLATFORM - Disclosed herein are apparatus, method, and system embodiments for securing a cloud-based point-of-sale device. An embodiment includes a processing module and a communication module. The processing module is configured to operate with an operating system (OS) secured against alteration and to perform one or more purchase transactions. The communication module is configured to selectively enable acceptance of data via a secure communications path. | 07-16-2015 |
Scott D. Power, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20120252101 | VARIANTS OF BACILLUS SP. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES - Variants of | 10-04-2012 |
Travis W. Power, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20080304947 | Cleanout system for a reciprocating slat conveyor - A sheet member ( | 12-11-2008 |